Literature DB >> 25597825

Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB.

Liping Pan1, Hongyan Jia1, Fei Liu1, Huishan Sun1, Mengqiu Gao2, Fengjiao Du1, Aiying Xing1, Boping Du1, Qi Sun1, Rongrong Wei1, Shuxiang Gu1, Zongde Zhang3.   

Abstract

OBJECTIVES: To investigate the risk factors for false-negative T-SPOT.TB results in patients with pulmonary TB (PTB) and extra-pulmonary TB (EPTB).
METHODS: Patients with suspected TB who underwent valid T-SPOT.TB tests were prospectively enrolled at Beijing Chest Hospital between November 2012 and November 2013. Basic characters and clinical laboratory findings were compared between true-positive and false-negative T-SPOT.TB groups.
RESULTS: Of 1928 suspected TB patients, 774 (530 PTB and 244 EPTB) microbiologically/histopathogenically-confirmed patients (636 culture-confirmed) were analyzed. Forty-six PTB patients (8.7%) and 32 EPTB patients (13.1%) had negative T-SPOT.TB results. Multivariate analysis showed that increased age [odds radio (OR) 2.26, 95% confidence interval (CI) 1.11-4.58], over-weight (BMI ≥ 25 kg/m(2), OR 2.43, 95% CI 1.05-5.63), and a longer period of illness before hospitalization (>6 months, OR 2.46, 95% CI 1.24-4.92) were independent risk factors for false-negative T-SPOT.TB results in PTB patients. In EPTB patients, increased age (OR 2.42, 95% CI 1.09-5.35) also showed an independent association with false-negative T-SPOT.TB results.
CONCLUSION: Careful interpretation of negative T-SPOT.TB results is necessary in older patients with suspected PTB or EPTB, and in PTB patients who are over-weight or have had longer periods of illness before hospitalization.
Copyright © 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extra-pulmonary TB; False-negative; Pulmonary TB; Risk factor; T-SPOT.TB

Mesh:

Substances:

Year:  2015        PMID: 25597825     DOI: 10.1016/j.jinf.2014.12.018

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  22 in total

1.  The risk factor of false-negative and false-positive for T-SPOT.TB in active tuberculosis.

Authors:  Li Di; Yan Li
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

2.  The performance of T-cell Xtend reagent in increasing blood storage times for interferon gamma release assays.

Authors:  Junlian Li; Yan Liu; Liyamu Ma; Libike Gu; Quan Wang; Miao Xu; Ruiying Ma; Yali Zhang; Zhenping Yang; Junjie Deng; Xing Yi
Journal:  J Clin Lab Anal       Date:  2017-07-03       Impact factor: 2.352

3.  Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.

Authors:  Wan-Li Kang; Gui-Rong Wang; Mei-Ying Wu; Kun-Yun Yang; A Er-Tai; Shu-Cai Wu; Shu-Jun Geng; Zhi-Hui Li; Ming-Wu Li; Liang Li; Shen-Jie Tang
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

4.  Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.

Authors:  Yu Zhou; Juan Du; Hong-Yan Hou; Yan-Fang Lu; Jing Yu; Li-Yan Mao; Feng Wang; Zi-Yong Sun
Journal:  Front Cell Infect Microbiol       Date:  2017-10-30       Impact factor: 5.293

5.  Prospective Comparison of QFT-GIT and T-SPOT.TB Assays for Diagnosis of Active Tuberculosis.

Authors:  Fengjiao Du; Li Xie; Yonghong Zhang; Fei Gao; Huibin Zhang; Wei Chen; Bingqi Sun; Wei Sha; Yong Fang; Hongyan Jia; Aiying Xing; Boping Du; Li Zheng; Mengqiu Gao; Zongde Zhang
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

6.  Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT®. TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China.

Authors:  Chi Yang; Shaojun Zhang; Lan Yao; Lin Fan
Journal:  J Int Med Res       Date:  2018-03-12       Impact factor: 1.671

7.  A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China.

Authors:  Shuguang Li; Liyan Lin; Feifei Zhang; Chunjiang Zhao; Han Meng; Hui Wang
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

8.  Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis.

Authors:  Mari Yamasue; Kosaku Komiya; Yuko Usagawa; Kenji Umeki; Shin-Ichi Nureki; Masaru Ando; Kazufumi Hiramatsu; Hideaki Nagai; Jun-Ichi Kadota
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

9.  Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age.

Authors:  Won Bae; Kyoung Un Park; Eun Young Song; Se Joong Kim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jae-Joon Yim; Choon-Taek Lee; Jae Ho Lee
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

10.  Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection.

Authors:  Ying Luo; Ying Xue; Guoxing Tang; Yimin Cai; Xu Yuan; Qun Lin; Huijuan Song; Wei Liu; Liyan Mao; Yu Zhou; Zhongju Chen; Yaowu Zhu; Weiyong Liu; Shiji Wu; Feng Wang; Ziyong Sun
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.